Copper metabolism of astrocytes

Frontiers in Aging Neuroscience

Volumn 5, Issue MAR, 2013, Pages

  Dringen, Ralf ^a   Scheiber, Ivo F ^b   Mercer, Julian F B ^c  

^a UNIVERSITY OF BREMEN   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

Astroglia; ATP7A; Copper export; Ctr1; Metallothioneins; Oxidative stress; Toxicity; Transport

Indexed keywords

COPPER ION; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C OXIDASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MENKES PROTEIN; METALLOTHIONEIN;

ARTICLE; ASTROCYTE; COPPER DEFICIENCY; COPPER METABOLISM; EXPOSURE; GLUCOSE INTAKE; HOMEOSTASIS; HUMAN; ION TRANSPORT; MENKES SYNDROME; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STORAGE; TRANS GOLGI NETWORK; WILSON DISEASE;

EID: 84883495202     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00009     Document Type: Article

References (34)

1. Arredondo, M., Munoz, P., Mura, C. V., and Nunez, M. T. (2003). DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 284, C1525-C1530.
2. Barnes, N., Tsivkovskii, R., Tsivkovskaia, N., and Lutsenko, S. (2005). The copper-transporting ATPases, Menkes and Wilson disease proteins, have distinct roles in adult and developing cerebellum. J. Biol. Chem. 280, 9640-9645.
3. Bolaños, J. P., and Heales, S. J. (2010). Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications. Front. Neuroenergetics 2:1. doi: 10.3389/neuro.14.001.2010
4. Brown, D. R. (2004). Role of the prion protein in copper turnover in astrocytes. Neurobiol. Dis. 15, 534-543.
5. Chen, S. H., Lin, J. K., Liu, S. H., Liang, Y. C., and Lin-Shiau, S. Y. (2008). Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol. Sci. 102, 138-149.
6. Double, K. L. (2012). Neuronal vulnerability in Parkinson's disease. Parkinsonism Relat. Disord. 18(Suppl. 1), S52-S54.
7. Dringen, R., Bishop, G. M., Koeppe, M., Dang, T. N., and Robinson, S. R. (2007). The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res. 32, 1884-1890.
8. Dringen, R., Pawlowski, P. G., and Hirrlinger, J. (2005). Peroxide detoxification by brain cells. J. Neurosci. Res. 79, 157-165.
9. Greenough, M. A., Camakaris, J., and Bush, A. I. (2013). Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem. Int. (in press).
10. Halliwell, B., and Gutteridge, J. M. (2007). Free Radicals in Biology and Medicine. New York, NY: Oxford University Press.
11. Haywood, S., Paris, J., Ryvar, R., and Botteron, C. (2008). Brain copper elevation and neurological changes in north ronaldsay sheep: a model for neurodegenerative disease? J. Comp. Pathol. 139, 252-255.
12. Huster, D. (2010) Wilson's disease. Best Pract. Res. Clin. Gastroenterol. 24, 531-539.
13. Kaler, S. G. (2011). ATP7A-related copper transport diseases - emerging concepts and future trends. Nat. Rev. Neurol. 7, 15-29.
14. Kodama, H., Fujisawa, C., and Bhadhprasit, W. (2011). Pathology, clinical features and treatments of congenital copper metabolic disorders - focus on neurologic aspects. Brain Dev. 33, 243-251.
15. Kodama, H., Meguro, Y., Abe, T., Rayner, M. H., Suzuki, K. T., Kobayashi, S., et al. (1991). Genetic expression of Menkes disease in cultured astrocytes of the macular mouse. J. Inherit. Metab. Dis. 14, 896-901.
16. Lee, J., Pena, M. M., Nose, Y., and Thiele, D. J. (2002). Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem. 277, 4380-4387.
17. Liddell, J. R., Bush, A. I., and White, A. R. (2013). "Copper in brain and neurodegeneration," in Encyclopedia of Inorganic and Bioinorganic Chemistry, Volume: Metals in Cells, eds V. Culotta and R. A. Scott (Chichester: Wiley). (in press).
18. Minich, T., Riemer, J., Schulz, J. B., Wielinga, P., Wijnhold, J., and Dringen, R. (2006). The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J. Neurochem. 97, 373-384.
19. Niciu, M. J., Ma, X. M., El Meskini, R., Pachter, J. S., Mains, R. E., and Eipper, B. A. (2007). Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease. Neurobiol. Dis. 27, 278-291.
20. Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H., Schousboe, A., Haydon, P. G., et al. (2012). Glial cells in (patho)physiology. J. Neurochem. 121, 4-27.
21. Qian, Y., Zheng, Y., Taylor, R., and Tiffany-Castiglioni, E. (2012). Involvement of the molecular chaperone Hspa5 in copper homeostasis in astrocytes. Brain Res. 1447, 9-19.
22. Reddy, P. V., Rao, K. V., and Norenberg, M. D. (2008). The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab. Invest. 88, 816-830.
23. Rivera-Mancia, S., Perez-Neri, I., Rios, C., Tristan-Lopez, L., Rivera-Espinosa, L., and Montes, S. (2010). The transition metals copper and iron in neurodegenerative diseases. Chem. Biol. Interact. 186, 184-199.
24. Robinson, N. J., and Winge, D. R. (2010). Copper metallochaperones. Annu. Rev. Biochem. 79, 537-562.
25. Rothstein, J. D., Dykes-Hoberg, M., Corson, L. B., Becker, M., Cleveland, D. W., Price, D. L., et al. (1999). The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain. J. Neurochem. 72, 422-429.
26. Scheiber, I. F., and Dringen, R. (2011a). Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocytes. Neurosci. Lett. 498, 42-46.
27. Scheiber, I. F., and Dringen, R. (2011b). Copper accelerates glycolytic flux in cultured astrocytes. Neurochem. Res. 36, 894-903.
28. Scheiber, I. F., and Dringen, R. (2013). Astrocyte functions in the copper homeostasis of the brain. Neurochem. Int. (in press).
29. Scheiber, I. F., Mercer, J. F., and Dringen, R. (2010a). Copper accumulation by cultured astrocytes. Neurochem. Int. 56, 451-460.
30. Scheiber, I. F., Schmidt, M. M., and Dringen, R. (2010b). Zinc prevents the copper-induced damage of cultured astrocytes. Neurochem. Int. 57, 314-322.
31. Scheiber, I. F., Schmidt, M. M., and Dringen, R. (2012). Copper export from cultured astrocytes. Neurochem. Int. 60, 292-300.
32. Schmidt, M. M., and Dringen, R. (2012). "GSH Synthesis and Metabolism," in Advances in Neurobiology. Neural Metabolism in vivo, Vol. 4, eds R. Gruetter and I. Y. Choi (New York, NY: Springer), 1029-1050.
33. Szerdahelyi, P., and Kasa, P. (1986). Histochemical demonstration of copper in normal rat brain and spinal cord. Evidence of localization in glial cells. Histochemistry 85, 341-347.
34. Tiffany-Castiglioni, E., Hong, S., and Qian, Y. (2011). Copper handling by astrocytes: insights into neurodegenerative diseases. Int. J. Dev. Neurosci. 29, 811-818.